Abstract:Recent studies have indicated that homeobox A3 (HOXA3) functions as a carcinogen in colon cancer and the methylation level of HOXA3 is significantly increased in lung adenocarcinoma (LUAD) tissues. However, at least to the best of our knowledge, few studies to date have been performed on HOXA3 in non-small cell lung cancer (NSCLC). Therefore, further studies on HOXA3 expression in NSCLC and the potential regulatory mechanisms are urgently required. In this study, HOXA3 expression in 55 tissues of cases of NSCLC and corresponding non-lung cancer tissues was detected by reverse transcription-quantitative PCR (RT-qPCR). In addition, the clinical significance of HOXA3 expression in NSCLC was evaluated using the Cancer Genome Atlas (TCGA) database. Bioinformatics analysis was then performed to elucidate the potential molecular mechanisms of action of HOXA3. Furthermore, the potential target microRNAs (miRNAs or miRs) of HOXA3 were predicted using miRWalk2.0. Based on Gene Expression Omnibus (GEO) and TGCA databases, standardized mean difference (SMD) and sROC methods were used for meta-analyses of the expression of potential target miRNAs of HOXA3 in NSCLC to evaluate their association with HOXA3. The results revealed that the HOXA3 expression levels in NSCLC, LUAD and lung squamous cell carcinoma (LUSC) were 0.1130±0.1398, 0.1295±0.16890 and 0.0906±0.0846, respectively. These values were all decreased compared with the normal tissues (0.1877±0.1975, 0.2337±0.2405 and 0.1249±0.0873, respectively, P<0.05). The TCGA database also revealed the low expression trend of HOXA3. The downregulation of HOXA3 may play an important role in the progression and the poor prognosis of LUAD. The TCGA database also suggested that HOXA3 in LUAD and LUSC tissues exhibited certain mutational levels. In addition, the methylation levels in the NSCLC, LUAD and LUSC tissues significantly increased [NSCLC: fold change (FC), 1.3226; P<0.001; LUAD: FC, 1.2712; P<0.001; and LUSC: FC, 1.3786; P<0.001]. According to the analyses using the Kyoto Encyclopedia of Genes and Genomes (KEGG), we found that the co-expression HOXA3 genes were mainly associated with the focal adhesion signalling pathway and the ECM-receptor interaction signalling pathway. Furthermore, the predicted miRNA, miR-372-3p, exhibited a high expression in both the NSCLC and LUAD tissues (P<0.05). On the whole, the findings of this study indicate that low HOXA3 expression may play a certain role in LUAD; however, its association with LUSC still requires further investigation. HOXA3 function may be achieved through different pathways or target miRNAs. However, the specific underlying mechanisms need to be confirmed through various functional studies.

Evaluation of the HOXA11 Level in Patients with Lung Squamous Cancer and Insights into Potential Molecular Pathways Via Bioinformatics Analysis

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Proteomic and Phosphoproteomic Maps of Lung Squamous Cell Carcinoma from Chinese Patients.

Upregulation Of Hoxa13 As A Potential Tumorigenesis And Progression Promoter Of Lusc Based On Qrt-Pcr And Bioinformatics

Upregulation of HOXA11 during the progression of lung adenocarcinoma detected via multiple approaches

Comprehensive Clinical Implications of Homeobox A10 in 3,199 Cases of Non-Small Cell Lung Cancer Tissue Samples Combining Qrt-Pcr, RNA Sequencing and Microarray Data.

Clinical Significance and Effect of Lncrna HOXA11-AS in NSCLC: A Study Based on Bioinformatics, in Vitro and in Vivo Verification

Upregulation of HOXA1 Promotes Tumorigenesis and Development of Non‑small Cell Lung Cancer: A Comprehensive Investigation Based on Reverse Transcription-Quantitative Polymerase Chain Reaction and Bioinformatics Analysis.

HOXC11 Drives Lung Adenocarcinoma Progression Through Transcriptional Regulation of SPHK1.

Expression Landscape and Functional Roles of HOXA4 and HOXA5 in Lung Adenocarcinoma

Systematic Analysis Using a Bioinformatics Strategy Identifies SFTA1P and LINC00519 As Potential Prognostic Biomarkers for Lung Squamous Cell Carcinoma

Identification of tumor-suppressor genes in lung squamous cell carcinoma through integrated bioinformatics analyses

Homeobox-A13 Acts As a Functional Prognostic and Diagnostic Biomarker Via Regulating P53 and Wnt Signaling Pathways in Lung Cancer.

Downregulation of HOXA3 in Lung Adenocarcinoma and Its Relevant Molecular Mechanism Analysed by RT-qPCR, TCGA and in Silico Analysis

Comprehensive Analysis of the Long Noncoding RNA HOXA11-AS Gene Interaction Regulatory Network in NSCLC Cells.

Prospective target gene network of key miRNAs influenced by long non-coding RNA HOXA 11-AS in NSCLC cells

The Underlying Molecular Mechanism and Identification of Transcription Factor Markers for Laryngeal Squamous Cell Carcinoma.

Exploring the prognosis value, immune correlation, and drug responsiveness prediction of homeobox C6 (HOXC6) in lung adenocarcinoma

Emerging Role of HOX Genes and Their Related Long Noncoding RNAs in Lung Cancer

Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis

Identification of key genes related to the mechanism and prognosis of lung squamous cell carcinoma using bioinformatics analysis